Nantahala Capital Management, Llc - Net Worth and Insider Trading

Nantahala Capital Management, Llc Net Worth

The estimated net worth of Nantahala Capital Management, Llc is at least $25 Million dollars as of 2024-04-29. Nantahala Capital Management, Llc is the 10% Owner of Sucampo Pharmaceuticals Inc and owns about 1,414,361 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $25 Million. Details can be seen in Nantahala Capital Management, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nantahala Capital Management, Llc has not made any transactions after 2012-04-23 and currently still holds the listed stock(s).

Transaction Summary of Nantahala Capital Management, Llc

Nantahala Capital Management, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nantahala Capital Management, Llc owns 5 companies in total, including ImageWare Systems Inc (IWSY) , GUE Liquidation Co Inc (FTDCQ) , and Viveve Medical Inc (VIVE) among others .

Click here to see the complete history of Nantahala Capital Management, Llc’s form 4 insider trades.

Insider Ownership Summary of Nantahala Capital Management, Llc

Ticker	Comapny	Transaction Date	Type of Owner
IWSY	ImageWare Systems Inc	2020-10-12	10 percent owner
FTDCQ	GUE Liquidation Co Inc	2019-06-13	10 percent owner
VIVE	Viveve Medical Inc	2019-04-25	10 percent owner
SCMP	Sucampo Pharmaceuticals Inc	2012-04-23	10 percent owner
AYTU	Aytu BioPharma Inc	2023-06-13	10 percent owner

Nantahala Capital Management, Llc Latest Holdings Summary

Nantahala Capital Management, Llc currently owns a total of 1 stock. Nantahala Capital Management, Llc owns 1,414,361 shares of Sucampo Pharmaceuticals Inc (SCMP) as of April 23, 2012, with a value of $25 Million.

Latest Holdings of Nantahala Capital Management, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SCMP	Sucampo Pharmaceuticals Inc	2012-04-23	1,414,361	18.00	25,458,498

Holding Weightings of Nantahala Capital Management, Llc

Nantahala Capital Management, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Nantahala Capital Management, Llc has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 219,900 shares on April 23, 2012, which brought Nantahala Capital Management, Llc around $2 Million.

Insider Trading History of Nantahala Capital Management, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nantahala Capital Management, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nantahala Capital Management, Llc Ownership Network

Ownership Network List of Nantahala Capital Management, Llc

No Data

Ownership Network Relation of Nantahala Capital Management, Llc

Nantahala Capital Management, Llc Owned Company Details

What does ImageWare Systems Inc do?

Who are the key executives at ImageWare Systems Inc?

Nantahala Capital Management, Llc is the 10 percent owner of ImageWare Systems Inc. Other key executives at ImageWare Systems Inc include 10 percent owner Neal I Goldman , SVP and CFO Jay B Lewis , and 10 percent owner Nantahala Capital Partners Ii Limited Partnership .

ImageWare Systems Inc (IWSY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ImageWare Systems Inc (IWSY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImageWare Systems Inc (IWSY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ImageWare Systems Inc (IWSY)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImageWare Systems Inc Insider Transactions

No Available Data

What does GUE Liquidation Co Inc do?

Who are the key executives at GUE Liquidation Co Inc?

Nantahala Capital Management, Llc is the 10 percent owner of GUE Liquidation Co Inc. Other key executives at GUE Liquidation Co Inc include 10 percent owner Morris Lichtenstein , 10 percent owner Daniel Mack , and 10 percent owner Wilmot B. Harkey .

GUE Liquidation Co Inc (FTDCQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GUE Liquidation Co Inc (FTDCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GUE Liquidation Co Inc (FTDCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GUE Liquidation Co Inc (FTDCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

GUE Liquidation Co Inc Insider Transactions

No Available Data

What does Viveve Medical Inc do?

Who are the key executives at Viveve Medical Inc?

Nantahala Capital Management, Llc is the 10 percent owner of Viveve Medical Inc. Other key executives at Viveve Medical Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and 10 percent owner Wilmot B. Harkey .

Viveve Medical Inc (VIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Viveve Medical Inc (VIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viveve Medical Inc (VIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viveve Medical Inc (VIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viveve Medical Inc Insider Transactions

No Available Data

What does Sucampo Pharmaceuticals Inc do?

Who are the key executives at Sucampo Pharmaceuticals Inc?

Nantahala Capital Management, Llc is the 10 percent owner of Sucampo Pharmaceuticals Inc. Other key executives at Sucampo Pharmaceuticals Inc include Chief Executive Officer Peter Greenleaf , CFO Peter P. Pfreundschuh , and Chief Science Officer Peter A Kiener .

Sucampo Pharmaceuticals Inc (SCMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sucampo Pharmaceuticals Inc (SCMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sucampo Pharmaceuticals Inc (SCMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sucampo Pharmaceuticals Inc (SCMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sucampo Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Nantahala Capital Management, Llc is the 10 percent owner of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Nantahala Capital Management, Llc made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 348,371 shares made by Joshua R. Disbrow , a net purchase of 100,000 shares made by Greg Pyszczymuka , and a net purchase of 90,000 shares made by Mark K Oki .

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 40,219 shares were bought by its insiders, resulting in a net purchase of 40,219 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aytu BioPharma Inc Insider Transactions

No Available Data

Nantahala Capital Management, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Nantahala Capital Management, Llc. You might contact Nantahala Capital Management, Llc via mailing address: 130 Main St., 2nd Floor, New Canaan Ct 06840.

Discussions on Nantahala Capital Management, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.